Nascent Biotech, Inc. (NBIO)
OTCMKTS: NBIO · Delayed Price · USD
0.0764
-0.0135 (-15.02%)
Jun 20, 2024, 12:47 PM EDT - Market open

Nascent Biotech Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Year
20222021202020192018 2017 - 2012
Net Income
-2.8-0.15-1.31-4.09-1.37
Upgrade
Depreciation & Amortization
1.340000
Upgrade
Share-Based Compensation
0.680.120.791.10
Upgrade
Other Operating Activities
-1.010.45-0.462.430.66
Upgrade
Operating Cash Flow
-1.790.41-0.99-0.55-0.71
Upgrade
Common Stock Issued
0.2100.640.120.64
Upgrade
Other Financing Activities
1.66-0.320.350.310.08
Upgrade
Financing Cash Flow
1.87-0.320.990.430.73
Upgrade
Net Cash Flow
0.080.09-0-0.130.01
Upgrade
Free Cash Flow
-1.790.41-0.99-0.55-0.71
Upgrade
Free Cash Flow Margin
-41.35%-131.57%--
Upgrade
Free Cash Flow Per Share
-0.020.00-0.01-0.02-0.02
Upgrade
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.